![Kawasaki disease is a rare condition. It is most common in children under five years old and most cases occur in children aged between nine months and. - ppt download Kawasaki disease is a rare condition. It is most common in children under five years old and most cases occur in children aged between nine months and. - ppt download](https://images.slideplayer.com/13/3936913/slides/slide_26.jpg)
Kawasaki disease is a rare condition. It is most common in children under five years old and most cases occur in children aged between nine months and. - ppt download
![Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram](https://www.researchgate.net/publication/271648755/figure/tbl2/AS:667598358323206@1536179260261/Demographic-data-for-study-cohort_Q320.jpg)
Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram
Environmental epidemiology of Kawasaki disease: Linking disease etiology, pathogenesis and global distribution
![Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram](https://www.researchgate.net/publication/271648755/figure/fig2/AS:667598354120741@1536179259976/Cumulative-recurrence-rates-of-Kawasaki-disease-calculated-by-different-case-definitions_Q320.jpg)
Cumulative recurrence rates of Kawasaki disease calculated by different... | Download Scientific Diagram
![Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML](https://www.mdpi.com/medicina/medicina-56-00145/article_deploy/html/images/medicina-56-00145-g001-550.jpg)
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML
![Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study | Pediatrics Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study | Pediatrics](https://www.frontiersin.org/files/Articles/450713/fped-07-00121-HTML-r1/image_m/fped-07-00121-g001.jpg)
Frontiers | Increased Incidence of Kawasaki Disease in Taiwan in Recent Years: A 15 Years Nationwide Population-Based Cohort Study | Pediatrics
![Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics](https://www.frontiersin.org/files/Articles/431147/fped-07-00011-HTML/image_m/fped-07-00011-g001.jpg)
Frontiers | Thirty Years of Kawasaki Disease: A Single-Center Study at the University Hospital of Lausanne | Pediatrics
![Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5d113c51-9037-44ef-bf21-ef221a51cd49/gr1.gif)
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
![Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/42b7004d-c481-405d-8d94-441838b60ddf/jah32384-fig-0001.gif)